Frontiers in Medicinal Chemistry 2017 (FIMC'17)

The international symposium will focus on state-of-the-art technologies and novel approaches in the field of medicinal chemistry. The scientific program will include plenary lectures, short lectures, and poster presentations.

The international symposium will focus on state-of-the-art technologies and novel approaches in the field of medicinal chemistry. The scientific program will include plenary lectures, short lectures, and poster presentations. Furthermore, oral communications of postdoctoral junior scientists will be considered. It is the goal of the organizers to make this meeting an event of scientific excellence, attractive to both industrial and academic scientists in Medicinal Chemistry and related fields of research. 

Confirmed Speakers:

• Alexander Adibekian, University of Geneva/CH
• Eva Altmann, Novartis/CH
• Christoph Boss, Actelion/CH
• Jay Bradner, Novartis/CH
• A. Brunschweiger, University of Dortmund/DE
• Amedeo Caflish, University of Zürich/CH
• Craig Crews, Yale University/US
• Beat Fierz, EPFL/CH
• Jürg Gertsch, University of Bern/CH
• Peter Gmeiner, University of Erlangen/DE
• Michael Groll, TU München/DE
• Klemens Hoegenauer, Novartis/CH
• Marcus Koppitz, Bayer/DE
• Hans Matter, Sanofi/DE
• Ralph Mazitschek, Broad Institute/US
• Klaas Poelstra, niversity of Groningen/NL
• Matthias Rarey, University of Hamburg/DE
• Kurt Ritter, Sanofi/DE
• Sven Rottenberg, University of Bern/DE
• Gisbert Schneider, ETHZ/CH
• Patrick Schnider, Roche/CH
• Laurent Schio, Sanofi/FR
• Hilmar Weinmann, Bayer/DE

Contact:

Prof. Dr. Jean-Louis Reymond
Universität Bern
Departement für Chemie und Biochemie
Freiestr. 3
3012 Bern, Switzerland